[12] Giess M., Munoz-Lopez A., Buchmuller B., Kubik G., Summerer D., „Programmable Protein-DNA Crosslinking for the Direct Capture and Quantification of 5-Formylcytosine”, J. Am. Chem. Soc. 2019, 141 (24), 9453-9547.
[11] Hammer S.C., Kubik G., Watkins E.J., Minges H., Huang S., Arnold F.H., „Anti-Markovnikov alkene oxidation by metal-oxo-mediated enzyme catalysis”, Science 2017, 358, 215-218. (Highlighted in “Research of the Year”, C&EN 2017, 95 (49), 19 and Synfacts 2018, 14 (1), 83.)
[10] Flade S., Jasper J., Giess M., Juhasz M., Dankers A., Kubik G., Koch O., Weinhold E., Summerer D., „The N6-Position of Adenine is a Blind Spot for TAL-Effectors that Enables Effective Binding of Methylated and Fluorophore-Labeled DNA”, ACS Chem. Biol. 2017, 12 (7), 1719–1725.
[9] Rathi P., Maurer S., Kubik G., Summerer D., „Isolation of Human Genomic DNA Sequences with Expanded Nucleobase Selectivity”, J. Am. Chem. Soc. 2016, 138 (31), 9910–9918.
[8] Kubik G., Summerer D., „TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis”, ChemBioChem 2016, 17 (11), 975-980.
[7] Kubik G., Summerer D., „Deciphering Epigenetic Cytosine Modifications by Direct Molecular Recognition”, ACS Chem. Biol. 2015, 10, 1580-1589.
[6] Kubik G., Batke S., Summerer D., „Programmable Sensors of 5‑Hydroxymethylcytosine”, J. Am. Chem. Soc. 2015, 137 (1), 2-5.
[5] Kubik G., Summerer D., „Achieving single nucleotide resolution of 5‑methylcytosine detection with TALEs”, ChemBioChem 2015, 16 (2), 228-231.
[4] Kubik G., Schmidt M.J., Penner J.E., Summerer D., „Programmable and Highly Resolved in vitro Detection of 5-Methylcytosine by TALEs“, Angew. Chem. Int. Ed. 2014, 23, 6002-6006.
[3] Haven T., Kubik G., Haubenreisser S., Niggemann M., „Calcium Catalyzed Cyclopropanation”, Angew. Chem. Int. Ed. 2013, 14, 4016-4019. (Highlighted in Synfacts 2013, 9 (6), 619.)
[2] Ma G., Lin S., Ibrahem I., Kubik G., Liu L., Sun J., Córdova A., „Achiral Co-Catalyst Induced Switches in Catalytic Asymmetric Reactions on Racemic Mixtures (RRM): From Stereodivergent RRM to Stereoconvergent Deracemization by Combination of Hydrogen Bond Donating and Chiral Amine Catalysts”, Adv. Synth. Catal. 2012, 14-15, 2865–2872.
[1] Giese M., Albrecht M., Wiemer K., Kubik G., Valkonen A., Rissanen K., „Weak Intermolecular Anion–π Interactions in Pentafluorobenzyl-Substituted Ammonium Betaines“, Eur. J. Inorg. Chem. 2012, 18, 2995–2999.
Patente
[3] Hu Hu (胡虎), Marco Bocola (马克·博科拉), Grzegorz Kubik (格雷戈日·库比克), Chen Haibin (陈海滨), Jin Ou Ping (金炉萍), “Method for synthesizing R-3-(2-chloro-1-hydroxyethyl) phenol, phenylephrine, and eye drops” 2020, CN111378695A, filed by Enzymaster Ningbo Bio Engineering Co ltd. (Ausstehend)
[2] Summerer D., Kubik G., Giess M., Maurer S., “Transcription Activator-Like Effector (TALE)-based Decoding of Cytosine Nucleobases by Selective Modification Response” 2016, EP3214183 A1, filed by the University of Konstanz. (Erteilt)
[1] Summerer D., Kubik G., Schmidt M.J., “Direct, programmable detection of epigenetic cytosine modifications using TAL effectors” 2014, PCT/EP2014/001753, filed by the University of Konstanz. (Erteilt)
Sonstige
[2] Schiffels J., Kubik G., Dick M., „Synthetische Biologie: Mikroben für Cannabis‐Wirkstoffe“, Nachrichten aus der Chemie 2021, 69, 26-29.
[1] Kubik G., Chen H., Bocola M., Bong Y.K., Daußmann T., „Sustainable biocatalytic synthesis of β-hydroxy-α-amino acids on an industrial scale “, PharmaChem 2019, 5/6, 2-4.
Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB